Page last updated: 2024-11-07
beta-mercaptolactate
Description
beta-mercaptolactate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
3-mercaptolactic acid : A (2R)-2-hydroxy monocarboxylic acid consisting of lactic acid having a sulfanyl group at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 160645 |
| CHEBI ID | 197142 |
| SCHEMBL ID | 456685 |
| MeSH ID | M0052124 |
Synonyms (18)
| Synonym |
|---|
| 2614-83-7 |
| beta-mercaptolactate |
| AKOS006375428 |
| b-mercaptolactic acid |
| CHEBI:197142 |
| 2-hydroxy-3-sulanylpropanoic acid |
| 2-hydroxy-3-sulfanylpropanoic acid |
| 3-mercaptolactic acid |
| 2-hydroxy-3-mercaptopropionic acid |
| propanoic acid, 2-hydroxy-3-mercapto- |
| SCHEMBL456685 |
| ss-thiomilchsaure |
| 2-hydroxy-3-sulfanyl-propanoate |
| beta-mercaptolactic acid |
| b-mercaptolactate |
| 2-hydroxy-3-mercaptopropanoic acid |
| DTXSID90863000 |
| STARBLD0042055 |
Drug Classes (1)
| Class | Description |
|---|
| monosaccharide | Parent monosaccharides are polyhydroxy aldehydes H[CH(OH)]nC(=O)H or polyhydroxy ketones H-[CHOH]n-C(=O)[CHOH]m-H with three or more carbon atoms. The generic term 'monosaccharide' (as opposed to oligosaccharide or polysaccharide) denotes a single unit, without glycosidic connection to other such units. It includes aldoses, dialdoses, aldoketoses, ketoses and diketoses, as well as deoxy sugars, provided that the parent compound has a (potential) carbonyl group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.95
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 11.95 (24.57) | | Research Supply Index | 2.20 (2.92) | | Research Growth Index | 4.14 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |